Targeted fab fragments dismantle the allergy trigger
Allergic diseases represent a major global health burden, placing significant strain on healthcare systems worldwide. Severe conditions such…
Improving survival in people with severe psychiatric disorders
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
Incretin-based diabetes drugs show potential protective effects against dementia
A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes,…
How bariatric surgery outperforms GLP-1 in body fat loss
A large real-world study reveals how surgery and GLP-1 therapies reshape fat and lean tissue differently over time,…
Vitamin A derivative suppresses immune response and cancer vaccine efficacy
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by…
Silica nanomatrix enhances immunotherapy for solid tumors
Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of…
Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer
Dec 26 2025 A new study published today in Science Translational Medicine by researchers at The University of…
Opioid receptor agonists take advantage of new understanding of GPCR biology
 Opioid receptors are fantastic targets for treating pain—but unfortunately, the drugs that target them can be addictive.…
Blocking platelet-activating factor reduces liver damage in cirrhosis
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural…
How diabetes medications may influence cancer risk and progression
Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver,…
Cryo-EM reveals NPFFR1 activation and guides novel ligand design
This study investigates the molecular mechanisms underlying ligand recognition, subtype selectivity, and activation of neuropeptide FF receptor 1…
Exploring melatonin therapeutic potential in systemic lupus erythematosus
A recent review published in Current Molecular Pharmacology explores the therapeutic potential of melatonin in systemic lupus erythematosus…